SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001739614-24-000007
Filing Date
2024-02-28
Accepted
2024-02-28 09:12:36
Documents
15
Period of Report
2024-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K inhibrx-20240228.htm   iXBRL 8-K 26274
2 EX-99.1 exhibit99112312023.htm EX-99.1 88328
  Complete submission text file 0001739614-24-000007.txt   258748

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inhibrx-20240228.xsd EX-101.SCH 1928
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inhibrx-20240228_lab.xml EX-101.LAB 24851
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inhibrx-20240228_pre.xml EX-101.PRE 13061
16 EXTRACTED XBRL INSTANCE DOCUMENT inhibrx-20240228_htm.xml XML 3181
Mailing Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 (858) 795-4220
Inhibrx, Inc. (Filer) CIK: 0001739614 (see all company filings)

IRS No.: 824257312 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39452 | Film No.: 24690551
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)